News

Erythromycin in babies and infants has been associated with an increased risk of infantile hypertrophic pyloric stenosis.

Paediatricians have seen a huge rise in cases of anorexia nervosa and other food restriction disorders in this age group, with some reporting a doubling, tripling or even quadrupling of cases compared with the same period last year.

Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.

This guidance, updated in December 2020 and endorsed by RCPCH, has been produced to inform all healthcare professionals of best practice around the use and prescribing of valproate. It supports them to navigate situations that could arise as a result of prescribing valproate to women during childbea...

The Epilepsy12 Youth Advocates have been selected as joint winners in the HQIP Audit Heroes Awards 2020 in the Volunteer of the Year Category, recognising their hard work to support improvements in epilepsy care.

Paediatricians, health visitors and GPs have joined forces to produce guidance for parents who are worried about their new baby.

As part of our Shape of training programme, we asked thousands of children and young people what knowledge, skills and attitude the paediatrician of the future needs. The top themes? Being respectful, kind and friendly, being listened to and understood, having good communication focused on age and n...

Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...

Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.